Get Your Personalized Supplement StackSupplement Stack Quiz

Red Sage Powder

Also known as: Red Sage, Danshen, Chinese Red Sage, Chinese Sage, Red Root Sage, Salvia miltiorrhiza

Overview

Salvia miltiorrhiza, commonly known as Red Sage or Danshen, is a perennial plant native to China and a cornerstone of Traditional Chinese Medicine (TCM). It is widely utilized for its purported benefits in cardiovascular and circulatory health. The plant's therapeutic effects are attributed to its main bioactive compounds: tanshinones (lipophilic diterpenoids) and salvianolic acids (water-soluble phenolics). Available in various forms such as powder, extract, or as part of multi-herb formulations, Red Sage is primarily applied in improving blood flow, treating cardiovascular diseases like angina pectoris, managing chronic kidney disease (CKD), supporting bone health in osteoporosis, and aiding recovery in postoperative conditions such as endometriosis. Research on S. miltiorrhiza is extensive, including numerous randomized controlled trials and meta-analyses, though some studies exhibit methodological heterogeneity and risk of bias.

Benefits

Salvia miltiorrhiza offers several evidence-based benefits, particularly in cardiovascular health, chronic kidney disease, osteoporosis, and postoperative endometriosis. For cardiovascular health, meta-analyses and clinical trials indicate that Red Sage reduces blood viscosity and platelet aggregation, significantly improving symptoms of angina pectoris with reported efficacy rates up to 86.7% and ECG improvements in about 75% of patients. In chronic kidney disease (CKD), a meta-analysis of 32 RCTs found that S. miltiorrhiza or its extracts (Salvianolate, Tanshinone) as an adjunct therapy improved kidney function and delayed CKD progression without significant adverse effects, though the evidence quality was moderate to low due to potential bias. For osteoporosis, a systematic review of clinical and preclinical studies suggests S. miltiorrhiza inhibits osteoclastogenesis (bone resorption) and promotes osteoblastogenesis (bone formation) via specific signaling pathways (MAPK/NF-κB/NFATc1), with clinical efficacy ranging from 77% to 96.7% in TCM trials, often in combined formulations. Lastly, a meta-analysis on postoperative endometriosis indicates that S. miltiorrhiza-containing Chinese herbal medicine combined with GnRH-a therapy significantly reduces recurrence rates, with risk ratios around 0.22-0.28 depending on treatment duration.

How it works

Salvia miltiorrhiza exerts its therapeutic effects through a multi-faceted mechanism involving its active compounds, tanshinones and salvianolic acids. These compounds modulate various biological pathways, including the inhibition of platelet aggregation and reduction of blood viscosity, which are crucial for cardiovascular health. They also exhibit significant antioxidant and anti-inflammatory activities. In bone metabolism, S. miltiorrhiza modulates signaling pathways such as MAPK, NF-κB, and NFATc1, leading to the inhibition of osteoclastogenesis (bone resorption) and promotion of osteoblastogenesis (bone formation). Key molecular targets include platelets, endothelial cells, osteoclasts, osteoblasts, and renal cells. Tanshinones specifically inhibit collagen degradation and osteoclast differentiation, while salvianolic acids promote angiogenesis and osteogenesis. Both water-soluble and lipid-soluble components contribute to its bioactivity, with bioavailability varying by preparation form; ethanol extracts are rich in tanshinones, and water extracts are rich in salvianolic acids.

Side effects

Salvia miltiorrhiza is generally well tolerated, with meta-analyses of clinical trials reporting no significant adverse effects. Mild gastrointestinal discomfort has been reported rarely but is not common. However, caution is advised due to potential drug interactions, particularly with anticoagulants and antiplatelet drugs, as Red Sage possesses blood-thinning properties that could enhance their effects and increase the risk of bleeding. Therefore, individuals on blood thinners or with pre-existing bleeding disorders should use S. miltiorrhiza with extreme caution and under medical supervision. There is limited data regarding its safety during pregnancy and lactation, so it is generally avoided or used only with strict medical guidance in these special populations. Comprehensive safety data for long-term, high-dose use is still emerging, suggesting that while it is safe for adjunctive use, prolonged high-dose regimens warrant further investigation.

Dosage

The effective dosage of Salvia miltiorrhiza varies significantly depending on the specific preparation (e.g., raw powder, standardized extract), the indication being treated, and the concentration of active components like salvianolate or tanshinone. In clinical trials, standardized extracts have typically been administered in a range of 200 mg to 1,000 mg daily. Powder doses can vary widely and are less standardized. The timing of administration is generally daily, often as an adjunct to conventional therapies, such as GnRH-a for endometriosis. The form of the extract also influences its primary effects; water extracts are often favored for cardiovascular and renal benefits due to their higher salvianolic acid content, while ethanol extracts, richer in tanshinones, may be preferred for bone health. Due to the variability and potential interactions, particularly with blood thinners, it is crucial to consult a healthcare provider for personalized dosage recommendations and to ensure safe use.

FAQs

Is Red Sage safe for long-term use?

Current evidence suggests good safety for adjunctive use, but long-term high-dose safety data are limited. Consultation with a healthcare provider is recommended for prolonged use.

Can it be used with blood thinners?

Caution is advised due to its potential additive blood-thinning effects. It is crucial to consult with a healthcare provider before combining Red Sage with blood thinners.

How soon do benefits appear?

Clinical improvements in cardiovascular or renal parameters are often reported within weeks to months. Benefits for conditions like osteoporosis may require longer treatment durations.

Is it effective alone or only in combination?

Many studies utilize S. miltiorrhiza in combination with other herbs or conventional treatments. Its isolated efficacy is less extensively studied compared to its use in multi-component regimens.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9213127/ – This meta-analysis of 32 RCTs investigated the effects of S. miltiorrhiza or its extracts on chronic kidney disease. It found that S. miltiorrhiza as an adjunct therapy improved kidney function and delayed CKD progression without significant adverse effects, though the evidence quality was moderate due to risk of bias and heterogeneity.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.831850/full – This meta-analysis focused on the efficacy of S. miltiorrhiza-containing Chinese herbal medicine combined with GnRH-a therapy for postoperative endometriosis. It concluded that this combination significantly reduced recurrence rates (RR ~0.22-0.28), despite some heterogeneity in herbal formulations and small sample sizes.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1483431/pdf – This systematic review, including preclinical and clinical studies, explored S. miltiorrhiza's role in osteoporosis. It demonstrated that S. miltiorrhiza inhibits osteoclastogenesis and promotes osteoblastogenesis via MAPK/NF-κB/NFATc1 signaling pathways, with clinical efficacy ranging from 77% to 96.7% in TCM trials, often in combined herbal formulas.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5421141/ – This review of clinical trials on S. miltiorrhiza for cardiovascular diseases highlighted its ability to reduce blood viscosity and platelet aggregation, leading to improved angina symptoms. Overall efficacy was reported around 86.7%, though study quality varied and populations were predominantly Chinese.